Document is current

Any future updates will be listed below

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-016-2097-4

Published Online: 2016-02-08

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark